China SXT Pharmaceuticals, Inc. Gains 52.57%
Mon, Dec 12, 2022 at 06:59 PM
China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) rocketted at $0.88, representing a gain of 52.6%. On Mon, Dec 12, 2022, SXTC:NASDAQ hit a New 2-Week High of $0.88. From Mon, Nov 28, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 114.8%
- Engine Gaming and Media Inc. (GAME:NASDAQ), 95.03%
- FedNat Holding Company (FNHC:NASDAQ), 90%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 88.89%
- Edible Garden AG Incorporated (EDBL:NASDAQ), 59.36%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 57.2%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 55.53%
- Hyperfine Inc. (HYPR:NASDAQ), 53.75%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 52.57%